GAS5 and metastatic malignant neoplasm in the lymph nodes: In a previous study, we identified that patients with prostate cancer and the Ins/Del or Del/Del genotype of GAS5 rs145204276 were at a significantly decreased risk of pathological lymph node metastasis compared with those with the Ins/Ins genotype (odds ratio (OR)  =  0.545; p = 0.043) [12].